CollPlant Biotechnologies - ADR Financials
$3.49
As on 16-Sep-2026 11:35EDT
Market cap
$7 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-9.42
|
-14.09
|
-2.76
|
-13.70
|
2.50
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-0.03
|
-0.54
|
-1.16
|
28.92
|
-31.56
|
|||||
|
Cash from Financing Activities
|
--
|
3.10
|
0.01
|
1.11
|
1.87
|
38.76
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-10.32
|
-8.97
|
-14.50
|
-0.61
|
-15.13
|
0.22
|
|||||
|
Cash EPS ($)
|
--
|
-8.26
|
-13.59
|
-0.52
|
-14.17
|
0.94
|
|||||
|
Adjusted Book Value ($)
|
--
|
4.75
|
11.75
|
2.47
|
28.86
|
42.06
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
-7.36
|
-12.30
|
-0.24
|
-12.25
|
2.33
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
-7.38
|
-12.72
|
-0.32
|
-13.38
|
1.00
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-90.21
|
-69.14
|
-21.05
|
-40.34
|
0.84
|
|||||
|
ROE (%)
|
-185.10
|
-117.56
|
-79.46
|
-23.16
|
-43.73
|
0.96
|
|||||
|
ROA (%)
|
-83.30
|
-77.90
|
-62.87
|
-19.53
|
-38.04
|
0.76
|
|||||
|
EBIT Margin (%)
|
-3,318.25
|
-483.93
|
-3,221.75
|
-63.96
|
-5,649.16
|
1.75
|
|||||
|
Net Margin (%)
|
-3,376.35
|
-484.56
|
-3,225.05
|
-64.05
|
-5,660.54
|
1.52
|
|||||
|
Cash Profit Margin (%)
|
0.00
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-84.26
|
3.60
|
-0.95
|
35.65
|
-0.98
|
1.55
|
|||||
|
EBIT Growth (%)
|
6.91
|
30.85
|
-136.72
|
58.50
|
-6,264.60
|
104.77
|
|||||
|
Net Profit Growth (%)
|
5.28
|
30.83
|
-136.63
|
58.53
|
-7,241.35
|
104.10
|
|||||
|
EPS Growth (%)
|
14.73
|
0.38
|
-22.66
|
0.96
|
-69.48
|
1.03
|
|||||
|
Book Value Growth (%)
|
-67.16
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-0.16
|
-0.25
|
-10.43
|
-0.55
|
74.05
|
|||||
|
Price / Book Value
|
1.37
|
0.29
|
0.31
|
2.58
|
0.29
|
0.39
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-5.97
|
0.12
|
0.30
|
-8.37
|
1.10
|
-21.15
|
|||||
|
Close Price ($)
|
5.36
|
14.00
|
36.00
|
63.90
|
83.50
|
163.60
|
|||||
|
High Price ($)
|
49.80
|
49.80
|
67.50
|
139.70
|
168.20
|
242.60
|
|||||
|
Low Price ($)
|
4.95
|
13.00
|
32.40
|
47.00
|
42.70
|
102.50
|
|||||
|
Market Cap ($ Cr)
|
6.62
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.47
|
0.23
|
0.11
|
0.09
|
0.08
|
|||||
|
Short term debt to equity ratio
|
0.16
|
0.13
|
0.06
|
0.02
|
0.02
|
0.01
|
|||||
|
Current Ratio
|
2.27
|
2.53
|
4.44
|
8.62
|
10.20
|
14.96
|
|||||
|
Quick Ratio
|
1.99
|
2.31
|
4.29
|
8.40
|
9.74
|
14.60
|
|||||
|
Interest Coverage
|
-57.12
|
-764.93
|
-976.00
|
-700.90
|
-496.79
|
7.41
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
59.90
|
0.04
|
113.20
|
3.59
|
3.01
|
1.73
|
|||||
|
Asset Turnover
|
0.02
|
0.16
|
0.02
|
0.30
|
0.01
|
0.50
|
|||||
|
Receivable days
|
--
|
44.98
|
346.10
|
6.70
|
170.41
|
12.84
|
|||||
|
Inventory Days
|
--
|
105.90
|
79.14
|
126.59
|
310.69
|
213.41
|
|||||
|
Payable days
|
--
|
154.71
|
126.87
|
124.76
|
268.12
|
166.87
|
|||||
|
Cash Conversion Cycle
|
--
|
-3.84
|
298.37
|
8.53
|
212.97
|
59.39
|